BioCentury
ARTICLE | Company News

Vertex receives milestone

May 24, 2000 7:00 AM UTC

VRTX received a $10 million milestone from partner Aventis (AVE) under the companies' collaboration to develop HMR 3480/VX-740, an oral inhibitor of IL-1 beta converting enzyme to treat rheumatoid art...